curasan

Contact
curasan.de
+496027409000

curasan AG

Lindigstr. 4
63801 Kleinostheim
Germany
+496027409000
curasan.de
Contact
Profile Products News
Contact

About curasan

Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading firms in the field of regenerative medicine especially in bone and tissue regeneration. In addition to the synthetic Cerasorb® bone substitution and regeneration material, the company has developed a future-oriented product pipeline. The goal during the next few years is to have further medical products ready for market rollout via well-positioned contractual partners in various market segments.

Read more about curasan
Facts about curasan
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of curasan

Product portfolio

Show all

News about curasan

curasan

30-Mar-2011 | research and development

curasan AG: Novel bone regeneration material approved for sale in Europe

curasan AG has received European approval for a novel synthetic bone regeneration material. Osseolive® is a bioactive, poly-crystalline calcium-alkali- ...

Read news
curasan

11-Feb-2011 | business & finance

curasan AG signs sales agreement with Stryker S.A.

curasan AG has signed an agreement with Stryker S.A., Montreux, Switzerland, to sell and market bone replacement and regeneration materials for different ...

Read news
curasan

22-Oct-2010 | research and development

curasan AG: Bioactive bone regeneration material approved for sale in Europe

curasan AG has received European approval for its new granular bone regeneration material Ceracell®. Hans Dieter Rössler, CEO of curasan AG, considers the ...

Read news
curasan

27-May-2010 | business & finance

curasan AG: cooperation agreement for new product line

curasan AG has concluded a contract with Matricel GmbH, Herzogenrath, which secures exclusive rights for both companies over a jointly developed new ...

Read news
curasan

22-Feb-2010 | business & finance

curasan AG: New US subsidiary for orthopaedics

curasan AG is commencing the sale, through a subsidiary, of its synthetic bone regeneration material Cerasorb® M Ortho in the United States. The newly ...

Read news
curasan

11-Dec-2009 | research and development

curasan AG receives license for Osbone

curasan AG has received CE certification and, therefore, marketing authorization throughout Europe of the synthetic bone replacement material Osbone®. ...

Read news
curasan

12-Nov-2009 | science

Ben-Gurion University Signs R&D Agreement with German Company curasan AG

Ben-Gurion University of the Negev’s technology transfer company BGN Technologies has signed a collaboration agreement with the German company curasan AG, ...

Read news
curasan

15-Oct-2009 | business & finance

curasan to invest approximately 1 million euros in future growth

curasan AG is to invest in its future growth by implementing a technological investment programme amounting to approximately 1 million euros, despite the ...

Read news
Show more news about curasan

Here you will find curasan AG